Impact of drug therapy on the risk of death in patients with coronary heart disease (according to the data of registry of cardiovascular diseases, RECVASA)
The aim of the study was to evaluate the effect of the drug therapy assigned at the index visit on the risk of fatal outcome in outpatients with coronary heart disease within 24 months from the index visit, based on the data of registry of cardiovascular diseases (RECVASA). Follow-up feedback was 97...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Concilium Medicum
2017-09-01
|
| Series: | КардиоСоматика |
| Subjects: | |
| Online Access: | https://cardiosomatics.orscience.ru/2221-7185/article/viewFile/45348/pdf |
| _version_ | 1818600556094029824 |
|---|---|
| author | K. G Pereverzeva S. S Yakushin A. N Vorobyev M. M Lukyanov E. Yu Andreyenko A. V Zagrebelny A. D Deev |
| author_facet | K. G Pereverzeva S. S Yakushin A. N Vorobyev M. M Lukyanov E. Yu Andreyenko A. V Zagrebelny A. D Deev |
| author_sort | K. G Pereverzeva |
| collection | DOAJ |
| description | The aim of the study was to evaluate the effect of the drug therapy assigned at the index visit on the risk of fatal outcome in outpatients with coronary heart disease within 24 months from the index visit, based on the data of registry of cardiovascular diseases (RECVASA). Follow-up feedback was 97.4%, the survival rate - 90.6%. The study found that the prescribing of angiotensin-converting enzyme (ACE) inhibitors or ACE inhibitors/angiotensin receptor blockers II (ARB) was associated with reduction of all-cause mortality by 1.6 times (p=0.016) and 2.0 times (p=0.006), respectively, statins - by 1.6 times (p=0.038). The risk of death from cardiovascular causes in the case of prescribing of ACE inhibitors or ACE inhibitors/ARBs decreased by 2.1 times (p=0.0008) and 2.3 times (p=0.0008), respectively, statins - by 1,7 times (p=0.048). |
| first_indexed | 2024-12-16T12:37:22Z |
| format | Article |
| id | doaj.art-aa0d11b0ba644a02862012c345a9934a |
| institution | Directory Open Access Journal |
| issn | 2221-7185 2658-5707 |
| language | English |
| last_indexed | 2024-12-16T12:37:22Z |
| publishDate | 2017-09-01 |
| publisher | Concilium Medicum |
| record_format | Article |
| series | КардиоСоматика |
| spelling | doaj.art-aa0d11b0ba644a02862012c345a9934a2022-12-21T22:31:32ZengConcilium MedicumКардиоСоматика2221-71852658-57072017-09-0183495341014Impact of drug therapy on the risk of death in patients with coronary heart disease (according to the data of registry of cardiovascular diseases, RECVASA)K. G Pereverzeva0S. S Yakushin1A. N Vorobyev2M. M Lukyanov3E. Yu Andreyenko4A. V Zagrebelny5A. D Deev6I.P.Pavlov Ryazan State Medical University of the Ministry of Health of the Russian FederationI.P.Pavlov Ryazan State Medical University of the Ministry of Health of the Russian FederationI.P.Pavlov Ryazan State Medical University of the Ministry of Health of the Russian FederationNational Medical Research Center for Preventive Medicine of the Ministry of Health of the Russian FederationNational Medical Research Center for Preventive Medicine of the Ministry of Health of the Russian FederationNational Medical Research Center for Preventive Medicine of the Ministry of Health of the Russian FederationNational Medical Research Center for Preventive Medicine of the Ministry of Health of the Russian FederationThe aim of the study was to evaluate the effect of the drug therapy assigned at the index visit on the risk of fatal outcome in outpatients with coronary heart disease within 24 months from the index visit, based on the data of registry of cardiovascular diseases (RECVASA). Follow-up feedback was 97.4%, the survival rate - 90.6%. The study found that the prescribing of angiotensin-converting enzyme (ACE) inhibitors or ACE inhibitors/angiotensin receptor blockers II (ARB) was associated with reduction of all-cause mortality by 1.6 times (p=0.016) and 2.0 times (p=0.006), respectively, statins - by 1.6 times (p=0.038). The risk of death from cardiovascular causes in the case of prescribing of ACE inhibitors or ACE inhibitors/ARBs decreased by 2.1 times (p=0.0008) and 2.3 times (p=0.0008), respectively, statins - by 1,7 times (p=0.048).https://cardiosomatics.orscience.ru/2221-7185/article/viewFile/45348/pdfcoronary heart diseasestatinsangiotensin-converting enzyme inhibitorsangiotensin receptor blockers iiprognosis |
| spellingShingle | K. G Pereverzeva S. S Yakushin A. N Vorobyev M. M Lukyanov E. Yu Andreyenko A. V Zagrebelny A. D Deev Impact of drug therapy on the risk of death in patients with coronary heart disease (according to the data of registry of cardiovascular diseases, RECVASA) КардиоСоматика coronary heart disease statins angiotensin-converting enzyme inhibitors angiotensin receptor blockers ii prognosis |
| title | Impact of drug therapy on the risk of death in patients with coronary heart disease (according to the data of registry of cardiovascular diseases, RECVASA) |
| title_full | Impact of drug therapy on the risk of death in patients with coronary heart disease (according to the data of registry of cardiovascular diseases, RECVASA) |
| title_fullStr | Impact of drug therapy on the risk of death in patients with coronary heart disease (according to the data of registry of cardiovascular diseases, RECVASA) |
| title_full_unstemmed | Impact of drug therapy on the risk of death in patients with coronary heart disease (according to the data of registry of cardiovascular diseases, RECVASA) |
| title_short | Impact of drug therapy on the risk of death in patients with coronary heart disease (according to the data of registry of cardiovascular diseases, RECVASA) |
| title_sort | impact of drug therapy on the risk of death in patients with coronary heart disease according to the data of registry of cardiovascular diseases recvasa |
| topic | coronary heart disease statins angiotensin-converting enzyme inhibitors angiotensin receptor blockers ii prognosis |
| url | https://cardiosomatics.orscience.ru/2221-7185/article/viewFile/45348/pdf |
| work_keys_str_mv | AT kgpereverzeva impactofdrugtherapyontheriskofdeathinpatientswithcoronaryheartdiseaseaccordingtothedataofregistryofcardiovasculardiseasesrecvasa AT ssyakushin impactofdrugtherapyontheriskofdeathinpatientswithcoronaryheartdiseaseaccordingtothedataofregistryofcardiovasculardiseasesrecvasa AT anvorobyev impactofdrugtherapyontheriskofdeathinpatientswithcoronaryheartdiseaseaccordingtothedataofregistryofcardiovasculardiseasesrecvasa AT mmlukyanov impactofdrugtherapyontheriskofdeathinpatientswithcoronaryheartdiseaseaccordingtothedataofregistryofcardiovasculardiseasesrecvasa AT eyuandreyenko impactofdrugtherapyontheriskofdeathinpatientswithcoronaryheartdiseaseaccordingtothedataofregistryofcardiovasculardiseasesrecvasa AT avzagrebelny impactofdrugtherapyontheriskofdeathinpatientswithcoronaryheartdiseaseaccordingtothedataofregistryofcardiovasculardiseasesrecvasa AT addeev impactofdrugtherapyontheriskofdeathinpatientswithcoronaryheartdiseaseaccordingtothedataofregistryofcardiovasculardiseasesrecvasa |